InTest Past Earnings Performance
Past criteria checks 1/6
InTest's earnings have been declining at an average annual rate of -28.2%, while the Semiconductor industry saw earnings growing at 1.8% annually. Revenues have been growing at an average rate of 9.5% per year. InTest's return on equity is 0.6%, and it has net margins of 0.5%.
Key information
-28.18%
Earnings growth rate
-29.73%
EPS growth rate
| Semiconductor Industry Growth | 27.66% |
| Revenue growth rate | 9.55% |
| Return on equity | 0.57% |
| Net Margin | 0.49% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
INTT: Solid 2026 Outlook And Q4 Execution Will Support Measured Upside Potential
Analysts have raised their price expectations for inTEST to a range of about $14 to $19. They cited better-than-expected Q4 results and "solid" guidance through 2026 as the basis for the higher targets.
INTT: Multiyear Guidance Will Test Rich Rogoff’s Execution Against High Expectations
Analysts have lifted their price target on inTEST to $14 from $10, citing better-than-expected Q4 results, solid 2026 guidance, and updated assumptions for higher revenue growth and profit margins within a similar forward P/E framework. Analyst Commentary Recent research updates point to a mixed read for inTEST, with higher price targets anchored to Q4 outperformance and 2026 guidance, but also a clear sense that valuation, execution, and growth risk still matter for investors.
INTT: Q4 Beat And 2026 Outlook Will Support Higher Market Repricing
Analyst price targets on inTEST have shifted from a prior fair value estimate of about $10 to roughly $17.67, with the move supported by recent Q4 outperformance and "solid" 2026 guidance that prompted Street targets in the $14 to $19 range. Analyst Commentary Bullish Takeaways Bullish analysts point to the better than expected Q4 results as support for the higher fair value range, suggesting recent execution is tracking ahead of what was previously baked into targets around $10.INTT: Solid 2026 Guidance And Q4 Execution Will Support Higher Earnings Multiple
Analysts have nudged their fair value estimate for inTEST up from $19 to $20, citing recent price target increases to $14 and $19 following better-than-expected Q4 results and solid 2026 guidance. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 results and 2026 guidance as key reasons for lifting their fair value views, reflected in updated price targets of $14 and $19.INTT: Raised Outlook Into 2026 Will Support Repriced Earnings Multiple
Analysts have lifted their price target on inTEST to $19 from $12, citing recent Q4 outperformance, "solid" guidance into 2026, and updated assumptions for revenue growth, profit margins, discount rate, and future P/E. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 performance and the company's guidance into 2026 as key reasons for lifting their valuation ranges.INTT: Medical Device Test Order Will Support Balanced Outlook Through 2026
Analysts have slightly adjusted their price targets on inTEST, reflecting small refinements to discount rate, revenue growth, profit margin and future P/E assumptions within their updated models. Taken together, these changes point to a modestly revised view of the stock's potential value in dollar terms.INTT: Medical Device Testing Expansion Will Support Measured Outlook For 2026 Recovery
Analysts have trimmed their fair value estimate for inTEST to $10.00. This reflects slightly lower discount rate and future P/E assumptions alongside modestly adjusted revenue growth and profit margin expectations.INTT: Transition-Year Execution Will Set Up 2026 Recovery And Undervalued Upside
Analysts have raised their price target on inTEST to US$10 from US$8, indicating increased confidence in the company's longer term growth outlook as it moves past a transition year. Analyst Commentary Recent research highlights a more optimistic stance on inTEST, with the latest work describing 2025 as a transition year and pointing to the potential for growth in 2026.INTT: Transition-Year Execution And 2026 Recovery Outlook Will Support Bullish Thesis
Narrative Update: Analyst Price Target Shift for inTEST The consensus analyst price target for inTEST has moved up by US$2 to US$10 per share. This reflects analysts' higher confidence in the company's outlook as it progresses through a transition year and they look ahead to 2026.INTT 2026 Recovery Outlook Will Drive Confidence In Transition-Year Progress
Analysts have raised their price target on inTEST to $10 from $8 per share, reflecting increased confidence in the company’s positioning for a return to growth after its current transition period. Analyst Commentary Recent research commentary reflects a cautiously optimistic stance, with the latest price target increase framed against a backdrop of execution and macro risks that could weigh on the pace of inTEST's recovery.
Alfamation Integration And Malaysian Expansion Will Strengthen Future Prospects
Integration with Alfamation and innovative product lines are enhancing revenue and margins, leveraging synergies, and expanding the customer base.Revenue & Expenses Breakdown
How InTest makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 121 | 1 | 39 | 10 |
| 31 Dec 25 | 114 | -3 | 39 | 9 |
| 30 Sep 25 | 118 | -2 | 42 | 9 |
| 30 Jun 25 | 122 | -1 | 43 | 9 |
| 31 Mar 25 | 128 | 0 | 44 | 9 |
| 31 Dec 24 | 131 | 3 | 41 | 9 |
| 30 Sep 24 | 122 | 3 | 40 | 8 |
| 30 Jun 24 | 123 | 5 | 40 | 8 |
| 31 Mar 24 | 121 | 7 | 39 | 8 |
| 31 Dec 23 | 123 | 9 | 39 | 8 |
| 30 Sep 23 | 128 | 11 | 39 | 8 |
| 30 Jun 23 | 128 | 11 | 37 | 8 |
| 31 Mar 23 | 125 | 11 | 37 | 8 |
| 31 Dec 22 | 117 | 8 | 35 | 8 |
| 30 Sep 22 | 107 | 6 | 33 | 7 |
| 30 Jun 22 | 97 | 5 | 30 | 7 |
| 31 Mar 22 | 89 | 6 | 28 | 6 |
| 31 Dec 21 | 85 | 7 | 25 | 6 |
| 30 Sep 21 | 77 | 7 | 23 | 5 |
| 30 Jun 21 | 71 | 5 | 21 | 5 |
| 31 Mar 21 | 62 | 2 | 19 | 5 |
| 31 Dec 20 | 54 | -1 | 19 | 5 |
| 30 Sep 20 | 53 | 0 | 19 | 5 |
| 30 Jun 20 | 53 | 0 | 19 | 5 |
| 31 Mar 20 | 54 | 0 | 20 | 5 |
| 31 Dec 19 | 61 | 2 | 21 | 5 |
| 30 Sep 19 | 65 | 1 | 22 | 5 |
| 30 Jun 19 | 71 | 0 | 22 | 5 |
| 31 Mar 19 | 78 | 4 | 23 | 5 |
| 31 Dec 18 | 79 | 3 | 22 | 5 |
| 30 Sep 18 | 80 | -1 | 22 | 5 |
| 30 Jun 18 | 77 | 2 | 22 | 5 |
| 31 Mar 18 | 71 | -1 | 21 | 5 |
| 31 Dec 17 | 67 | 1 | 19 | 4 |
| 30 Sep 17 | 58 | 7 | 16 | 4 |
| 30 Jun 17 | 51 | 6 | 14 | 4 |
| 31 Mar 17 | 46 | 5 | 13 | 4 |
| 31 Dec 16 | 40 | 3 | 12 | 4 |
| 30 Sep 16 | 38 | 2 | 12 | 4 |
| 30 Jun 16 | 36 | 1 | 12 | 4 |
| 31 Mar 16 | 37 | 2 | 12 | 4 |
| 31 Dec 15 | 39 | 2 | 12 | 4 |
| 30 Sep 15 | 41 | 3 | 12 | 4 |
| 30 Jun 15 | 42 | 3 | 12 | 4 |
Quality Earnings: INTT has a large one-off loss of $1.3M impacting its last 12 months of financial results to 31st March, 2026.
Growing Profit Margin: INTT became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INTT's earnings have declined by 28.2% per year over the past 5 years.
Accelerating Growth: INTT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: INTT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Semiconductor industry (18.7%).
Return on Equity
High ROE: INTT's Return on Equity (0.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/26 12:03 |
| End of Day Share Price | 2026/05/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
InTest Corporation is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Maxwell Michaelis | Lake Street Capital Markets, LLC |
| Edward Jackson | Northland Capital Markets |
| Richard Ryan | Oak Ridge Financial Services Group Inc. |